此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Helius in Hypertension-I: The UK Hypertension Registry

2017年4月3日 更新者:Proteus Digital Health, Inc.
The purpose of this study is to demonstrate the use of a digital health offering in the management of persistent hypertension during chronic anti-hypertensive treatment.

研究概览

详细说明

In patients with persistent essential systolic hypertension,who are undergoing assessment of their current pharmaceutical burden for blood pressure control, a digital health offering is used (1) to provide automatic and passive electronic documentation of medication adherence and patterns of medication taking, (2) to assist providers in distinguishing inadequate medication adherence or pharmacologic unresponsiveness as the root cause for persistent hypertension, and (3) to inform management decisions (dose adjustment, medication addition or substitution, adherence counseling, referral to a hypertension specialist).

Participating patients wear an adhesive Wearable Sensor ("Patch") continuously with replacement after one week, and ingest an inert tablet ("Pill") containing an Ingestible Sensor daily whenever they take their prescribed anti-hypertensive drugs.

The Patch automatically detects and records the dates and times of each "Pill" ingestion, daily step count, sleep duration and sleep interruptions, and the circadian pattern of rest and activity. After completion of each Patch's use, the recorded data are downloaded and incorporated into a report that includes blood pressures that are obtained at the time of clinic visits at the beginning and after 2 weeks of service use.

The final report is generated automatically and provided electronically to practitioners for review with their patient. The information that is obtained is incorporated by practitioners in advising next steps for blood pressure management.

研究类型

观察性的

注册 (实际的)

151

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients having blood pressure (measured in mm Hg) ≥150 systolic or ≥90 diastolic during chronic treatment with 2 or more anti-hypertensive drugs, and age ≥80 years; or blood pressure ≥140 systolic or ≥90 diastolic during chronic treatment with 2 or more anti-hypertensive, and <80 years

描述

Inclusion Criteria:

  • Male or female of age ≥ 18 years
  • Essential hypertension, consisting of:

    1. Blood pressure ≥150 or ≥90 during chronic treatment with 2 or more drugs for patients ≥80 years of age; or,
    2. Blood pressure ≥140 or≥90) during chronic treatment with 2 or more drugs for patients <80 years of age
  • Ability to read and understand the instructions for participating
  • Capacity to read and to speak English proficiently
  • Capacity to provide informed consent

Exclusion Criteria:

  • History of skin sensitivity to adhesive medical tape or metals
  • History of acute or chronic dermatitis
  • Any other condition that in the investigators opinion would compromise patient safety while participating
  • Alcohol or other substance abuse
  • Terminal illness

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Frequency of Medication-taking (% Taking Adherence)
大体时间:2 weeks
Percent timing adherence is determined by the number of ingestion sensors detected by the wearable monitor, divided by the total number of ingestion sensors prescribed, for the 2 week-time frame.
2 weeks
Pattern of Medication-taking (% Scheduling Adherence)
大体时间:2 weeks
Percent scheduling adherence is determined by the number of ingestion sensors detected within a ± 2-hour time window around the prescribed dosing period, divided by the number of ingestion sensors detected by the wearable sensor during that dosing period, over the 2-week time frame.
2 weeks

次要结果测量

结果测量
措施说明
大体时间
Proportion of Patients Capable of Achieving Blood Pressure Control on Existing Treatment
大体时间:2 weeks
Percentage of participants
2 weeks
Change in Systolic and Diastolic Blood Pressure After Use of Digital Health Offering
大体时间:2 weeks
Decrease in systolic and diastolic blood pressure (measured in mm Hg) after 2 weeks when compared to baseline
2 weeks
Blood Pressure Management After Use of Digital Health Offering
大体时间:4 weeks
Summary of provider actions following review of final report with patient (dose or medication change, adherence counseling, referral to a hypertension specialist)
4 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Peter Godbehere, MD、North Brink Practice, Cambridgeshire UK

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2013年9月1日

初级完成 (实际的)

2014年12月1日

研究完成 (实际的)

2015年5月1日

研究注册日期

首次提交

2015年9月15日

首先提交符合 QC 标准的

2015年9月16日

首次发布 (估计)

2015年9月17日

研究记录更新

最后更新发布 (实际的)

2017年6月16日

上次提交的符合 QC 标准的更新

2017年4月3日

最后验证

2017年4月1日

更多信息

与本研究相关的术语

其他研究编号

  • PB-HELIUS

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅